Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant Headlines Puncture Strategy as Stock Drops: Opening Line
Bloomberg
Friday, June 13, 2014 - 9:44am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Allergan-Valeant Deal Gets Pershing Poison Pill Warning
Bloomberg
Friday, June 13, 2014 - 9:43am
tags:
Allergan, Valeant Pharmaceuticals, poison pill, M&A
Johnson & Johnson: A New Marketing Strategy Could Drive Growth
Seeking Alpha
Friday, June 13, 2014 - 9:30am
tags:
JNJ, R&D
Genomic Health's Oncotype DX Redefines Breast Cancer Therapy
Yahoo/Zacks.com
Friday, June 13, 2014 - 9:25am
tags:
Oncotype DX, breast cancer, Genomic Health, diagnostics
Bayer Looking to Expand Eylea's Label
Yahoo/Zacks.com
Friday, June 13, 2014 - 9:23am
tags:
Bayer, Eylea, BRVO
FDA approves Medtronic's CoreValve for larger group of patients with diseased heart valve
Yahoo/AP
Friday, June 13, 2014 - 9:23am
tags:
FDA, CoreValve, Medtronic, devices
Roche's Purchase Of Genia A Long-Term Move
Seeking Alpha
Friday, June 13, 2014 - 9:20am
tags:
Roche, Genia Technologies, M&A
Merck open to more biotech deals - research chief
Yahoo/Reuters
Friday, June 13, 2014 - 9:18am
tags:
Roger Perlmutter, R&D, M&A, Merck, biotech
FDA panel advises against large opioid-constipation drug safety trials
Yahoo/Reuters
Thursday, June 12, 2014 - 2:22pm
tags:
FDA, advisory panels, opioid-induced constipation
Preschoolers to Get ADHD Drug Vyvanse in Shire Study
Bloomberg
Thursday, June 12, 2014 - 2:21pm
tags:
ADHD, Vyvanse, Shire
Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong
Forbes
Thursday, June 12, 2014 - 2:18pm
tags:
Valeant Pharmaceuticals, R&D
As the Dow Declines, Why Are Pfizer and Merck Rising?
Motley Fool
Thursday, June 12, 2014 - 2:16pm
tags:
Pfizer, Merck
Inovio shares dive on cervical cancer vax speculation
Fierce Vaccines
Thursday, June 12, 2014 - 11:19am
tags:
Inovio, cervical cancer, vaccines, VGX-3100
Digital health: Inside Apple's meeting with the FDA
Mass Device
Thursday, June 12, 2014 - 11:17am
tags:
Apple, mHealth, FDA
FDA Opens Up its Big Data Treasure Trove to Public, Web Developers
Medical Device and Diagnostic Industry
Thursday, June 12, 2014 - 11:16am
tags:
FDA, Big Data
Novartis Japan’s Office Raided by Prosecutors, Adding to Probes
Bloomberg
Thursday, June 12, 2014 - 11:13am
tags:
Novartis, Japan, Diovan
Bristol-Myers hepatitis B drug patent ruled invalid by appeals court
Yahoo/Fly on the Wall
Thursday, June 12, 2014 - 11:12am
tags:
hepatitis B, Bristol-Myers Squibb, Teva Pharmaceuticals, patents
VALEANT: How A Canadian Pharmaceutical Company Could Destroy The Industry As We Know It
Yahoo/Business Insider
Thursday, June 12, 2014 - 10:09am
tags:
Valeant Pharmaceuticals, Allergan, M&A
BioDelivery Sciences could be bought by Endo
The Fly on the Wall
Thursday, June 12, 2014 - 10:04am
tags:
M&A, BioDelivery Sciences, Endo Health Solutions
Teva CFO eyes small US acquisitions
Globes, Israel
Thursday, June 12, 2014 - 10:03am
tags:
Teva Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.